Jim Cramer Endorses GE Aerospace Leadership Confidence Drives Market Attention QXO Takes Hostile Route in Pursuit of Beacon as Boardroom Dispute Escalates Vital Farms VITL Q1 2026 Results Miss Estimates EPS 003 vs 009 SEC Advances TrumpBacked Proposal to End Mandatory Quarterly Earnings Reports Apples AI Strategy From Laggard to Potential Market Leader Japan StateBacked Fund Reportedly Considers Sale of Chip Materials Maker JSR Enhanced Games Donald Trump JrBacked Steroid Olympics Set for Sunday Debut US Productivity Growth Slows in Q4 as Unit Labor Costs Rise Este Lauder Abandons Merger Talks with Spanish Beauty Rival Puig Berkshire Hathaway Boosts Delta and Alphabet Holdings in Latest Portfolio Shift Kura Oncology Q1 2026 Earnings Wider Loss as Clinical Progress Continues AXP Q1 2026 Earnings EPS Beats Estimates by 53 Shares Edge Higher TC Q3 2021 Earnings Significant EPS Miss as Losses Widen ONB Q1 2026 Earnings Narrow EPS Miss Slightly Below Estimates Stock Edges Higher Citizens Inc CIA Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher ALNT Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Gain Banco Macro BMA Slides 3 as Shares Test Key Support After Recent Volatility BioXcel Therapeutics BTAI Slips 088 as Stock Tests Support Near 107 BCB Bancorp Inc BCBP Gains Ground Rising Momentum Signals Potential Breakout DTE Energy Preferred DTB DTB Edges Higher in Quiet Trading Holding Near Support Camden National Corporation CAC Holds Near Support Amid Modest Decline Gamblingcom GAMB Q1 2026 Earnings Miss EPS 003 vs 010 Expected Gold IRA Fees in 2026 How Hidden Markups May Erode Retirement Savings ADP Report Shows Private Sector Added 109000 Jobs in April Exceeding Expectations Core Inflation Accelerates to 32 as FirstQuarter GDP Growth Disappoints at 2 New York Magazine Faces Reputational and Financial Scrutiny Over Plagiarism Probe Involving HighProfile Writer Quantum Computing Stocks Surge on 2 Billion US Government Funding Plan Central Garden Pet Company CENTA Q1 2026 Earnings Earnings Beat Driven by Operational Discipline Amid Mixed TopLine Signals Rani Therapeutics RANI Plunges Nearly 10 as Stock Tests Critical Support Level